ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,434.00
      0.16%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.785
      1.05%
      Bitcoin
      65,166.32
      -1.98%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bioenvision (MM) (BIVN)

      7. Bioenvision (MM) (BIVN) News

      BIVN

      Bioenvision (BIVN)

      Bioenvision (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BIVN
      DateTimeSourceHeadlineSymbolCompany
      04/09/20077:02AMBusiness WireBioenvision to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
      04/02/20076:59AMBusiness WireBioenvision Announces Registered Direct Offering of $30 Million in Common StockNASDAQ:BIVNBioenvision (MM)
      02/01/20077:00AMBusiness WireBioenvision Licenses Its Proprietary Antimicrobial Technology to Foster CorporationNASDAQ:BIVNBioenvision (MM)
      01/31/200712:12PMBusiness WireBioenvision to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on Thursday, February 8, 2007NASDAQ:BIVNBioenvision (MM)
      01/08/20077:00AMBusiness WireBioenvision to Present at 25th Annual JPMorgan Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
      12/11/20062:59PMBusiness WireNew Evoltra(R) Data Shows Impressive Response and Survival RatesNASDAQ:BIVNBioenvision (MM)
      12/10/20061:44PMBusiness WireBioenvision Announces Latest Data on Evoltra(R) in Pediatric and Adult LeukemiasNASDAQ:BIVNBioenvision (MM)
      12/05/20067:00AMBusiness WireBioenvision's Evoltra(R) Advertisement Wins Industry HonorNASDAQ:BIVNBioenvision (MM)
      12/04/20067:00AMBusiness WireBioenvision's Evoltra(R) Data Selected for Oral Presentation at ASH 2006 Annual MeetingNASDAQ:BIVNBioenvision (MM)
      11/28/20067:00AMBusiness WireBioenvision Appoints James S. Scibetta as New CFONASDAQ:BIVNBioenvision (MM)
      11/10/20067:00AMBusiness WireBioenvision Files to Start Trial of Clofarabine Gel for PsoriasisNASDAQ:BIVNBioenvision (MM)
      11/09/20067:00AMBusiness WireBioenvision Reports First Quarter 2007 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      11/03/20067:00AMBusiness WireBioenvision to Present at CIBC World Markets Seventeenth Annual Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
      11/02/20065:46PMBusiness WireBioenvision to Hold Fiscal 2007 First Quarter Financial Results Conference Call Thursday, November 9, 2006NASDAQ:BIVNBioenvision (MM)
      10/24/20067:00AMBusiness WireBioenvision Names Vice President of Regulatory AffairsNASDAQ:BIVNBioenvision (MM)
      10/23/20067:00AMBusiness WireBioenvision to Present at Rodman & Renshaw 8th Annual Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
      10/10/200610:00AMBusiness WireBioenvision Names New Member to Board of DirectorsNASDAQ:BIVNBioenvision (MM)
      09/22/20066:07PMBusiness WireBioenvision to Present at UBS Global Life Sciences ConferenceNASDAQ:BIVNBioenvision (MM)
      09/21/20069:46AMBusiness WireLatest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia; Formal European Launch of EvoltrNASDAQ:BIVNBioenvision (MM)
      09/18/20067:00AMBusiness WireBioenvision to Expand into Japan and Southeast Asia; Japanese Health Officials Endorse Bioenvision's Leukemia DrugNASDAQ:BIVNBioenvision (MM)
      09/14/20066:06PMBusiness WireBioenvision to Formally Launch Evoltra(R) Throughout Europe; Bioenvision To Showcase Leukemia Drug At International Pediatric OnNASDAQ:BIVNBioenvision (MM)
      09/11/20067:00AMBusiness WireBioenvision Reports 2006 Year-End Financial ResultsNASDAQ:BIVNBioenvision (MM)
      09/08/20061:43PMBusiness WireBioenvision's Suvus(TM) Lowers Viral Load in Chronic Hepatitis C; Randomized Study Data Presented at Scientific ConferenceNASDAQ:BIVNBioenvision (MM)
      09/08/20061:33PMBusiness WireBioenvision to Hold Fiscal 2006 Year-End Financial Results Conference Call Monday, September 11, 2006NASDAQ:BIVNBioenvision (MM)
      08/01/20067:00AMBusiness WireBioenvision's Data on Suvus(TM) in Chronic Hepatitis C to Be Released at Scientific Conference; Development Program in Avian FlNASDAQ:BIVNBioenvision (MM)
      06/21/20067:00AMBusiness WireNew Survival Data on Evoltra(TM) (Clofarabine) in Elderly AML Reported at European Hematology Association CongressNASDAQ:BIVNBioenvision (MM)
      06/12/20064:15PMBusiness WireBioenvision's Evoltra(TM) Data Selected for Presentation at EHA's 11th Annual CongressNASDAQ:BIVNBioenvision (MM)
      06/05/20067:00AMBusiness WireBioenvision's Evoltra(TM) (clofarabine) Prolongs Survival in Elderly AML Patients with Adverse Cytogenetics; Superior ResponseNASDAQ:BIVNBioenvision (MM)
      05/31/200611:24AMBusiness WireBioenvision Receives European Approval for Evoltra(TM); Orphan Drug Designation Gives Evoltra(TM) 10 Years Market Exclusivity iNASDAQ:BIVNBioenvision (MM)
      05/16/20067:00AMBusiness WireBioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R); Exporting Evoltra(R) Rights CommenceNASDAQ:BIVNBioenvision (MM)
       Showing the most relevant articles for your search:NASDAQ:BIVN